So what is TPM point of difference over TPGS that has been doing same since 1950? Lots of companies working with TPGS that is manufactured as a generic by many so why would any pharma be locked into TPM? That is what the whole business is about so unless POH can fund , produce and trial commercial product complete from start to the point of being able to market it to a pharma. Then why would a pharma take it up when quickly someone could possibly use TPGS to formulate product to same effect?
www.slideshare.net/StephenWu/vitamin-e-tpgs-story
Research Articles, page-19
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.001(50.0%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.3¢ | 0.2¢ | $52 | 21.66K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 6846739 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 41919123 | 29 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| AVE (ASX) Chart |